カテゴリ： 世界, 医療/バイオ, Market Monitor Global

精神刺激薬のグローバル市場展望 2023年-2029年：一般用医薬品、処方箋医薬品

■ 英語タイトル：Psychostimulants Market, Global Outlook and Forecast 2023-2029

調査会社Market Monitor Global社が発行したリサーチレポート（データ管理コード：MMG23DC14537）■ 発行会社/調査会社：Market Monitor Global
■ 商品コード：MMG23DC14537
■ 発行日：2023年12月
■ 調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
■ 産業分野：医薬品
■ ページ数：137
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥494,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥642,200見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥741,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Market Monitor Global社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[精神刺激薬のグローバル市場展望 2023年-2029年：一般用医薬品、処方箋医薬品]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査レポートは次の情報を含め、世界の精神刺激薬市場規模と予測を収録しています。・世界の精神刺激薬市場：売上、2018年-2023年、2024年-2029年
・世界の精神刺激薬市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の精神刺激薬市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「一般用医薬品」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

精神刺激薬のグローバル主要企業は、Alkermes、 Allergan、 Bristol-Myers Squibb、 Eli Lilly and Company、 GlaxoSmithKline、 Lundbeck、 Merck、 Pfizer、 Teva Pharmaceutical Industries、 Takeda Pharmaceutical、 Johnson and Johnson、 Sanofi、 Astrazeneca、 Bayer HealthCare Pharmaceuticals、 Boehringer Ingelheim GmbHなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、精神刺激薬のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界の精神刺激薬市場：タイプ別、2018年-2023年、2024年-2029年
世界の精神刺激薬市場：タイプ別市場シェア、2022年
・一般用医薬品、処方箋医薬品

世界の精神刺激薬市場：用途別、2018年-2023年、2024年-2029年
世界の精神刺激薬市場：用途別市場シェア、2022年
・病院、診療所、その他

世界の精神刺激薬市場：地域・国別、2018年-2023年、2024年-2029年
世界の精神刺激薬市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業における精神刺激薬のグローバル売上、2018年-2023年
・主要企業における精神刺激薬のグローバル売上シェア、2022年
・主要企業における精神刺激薬のグローバル販売量、2018年-2023年
・主要企業における精神刺激薬のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Alkermes、 Allergan、 Bristol-Myers Squibb、 Eli Lilly and Company、 GlaxoSmithKline、 Lundbeck、 Merck、 Pfizer、 Teva Pharmaceutical Industries、 Takeda Pharmaceutical、 Johnson and Johnson、 Sanofi、 Astrazeneca、 Bayer HealthCare Pharmaceuticals、 Boehringer Ingelheim GmbH

*************************************************************

・調査・分析レポートの概要
精神刺激薬市場の定義
市場セグメント
世界の精神刺激薬市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の精神刺激薬市場規模
世界の精神刺激薬市場規模：2022年 VS 2029年
世界の精神刺激薬市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの精神刺激薬の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の精神刺激薬製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：一般用医薬品、処方箋医薬品
精神刺激薬のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：病院、診療所、その他
精神刺激薬の用途別グローバル売上・予測

・地域別市場分析
地域別精神刺激薬市場規模 2022年と2029年
地域別精神刺激薬売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
Alkermes、 Allergan、 Bristol-Myers Squibb、 Eli Lilly and Company、 GlaxoSmithKline、 Lundbeck、 Merck、 Pfizer、 Teva Pharmaceutical Industries、 Takeda Pharmaceutical、 Johnson and Johnson、 Sanofi、 Astrazeneca、 Bayer HealthCare Pharmaceuticals、 Boehringer Ingelheim GmbH
...

This research report provides a comprehensive analysis of the Psychostimulants market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Psychostimulants market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Psychostimulants, challenges faced by the industry, and potential opportunities for market players.
The global Psychostimulants market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Psychostimulants market presents opportunities for various stakeholders, including Hospital, Clinic. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Psychostimulants market. Additionally, the growing consumer demand present avenues for market expansion.
The global Psychostimulants market was valued at US$ 1088.4 million in 2022 and is projected to reach US$ 1661.8 million by 2029, at a CAGR of 6.3% during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private＆government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The research report on the Psychostimulants market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Psychostimulants market.
Market Overview: The report provides a comprehensive overview of the Psychostimulants market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Non-prescription Drugs, Prescription), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Psychostimulants market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Psychostimulants market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Psychostimulants market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Psychostimulants market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Psychostimulants market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Psychostimulants market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Psychostimulants, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Psychostimulants market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Psychostimulants market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Non-prescription Drugs
Prescription
Market segment by Application
Hospital
Clinic
Other
Global Psychostimulants Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East＆Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East＆Africa
Major players covered
Alkermes
Allergan
Bristol-Myers Squibb
Eli Lilly and Company
GlaxoSmithKline
Lundbeck
Merck
Pfizer
Teva Pharmaceutical Industries
Takeda Pharmaceutical
Johnson and Johnson
Sanofi
Astrazeneca
Bayer HealthCare Pharmaceuticals
Boehringer Ingelheim GmbH
Outline of Major Chapters:
Chapter 1: Introduces the definition of Psychostimulants, market overview.
Chapter 2: Global Psychostimulants market size in revenue and volume.
Chapter 3: Detailed analysis of Psychostimulants manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Psychostimulants in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Psychostimulants capacity by region＆country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Introduction to Research＆Analysis Reports
1.1 Psychostimulants Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Psychostimulants Market Overview
1.4 Features＆Benefits of This Report
1.5 Methodology＆Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions＆Caveats
2 Global Psychostimulants Overall Market Size
2.1 Global Psychostimulants Market Size: 2022 VS 2029
2.2 Global Psychostimulants Revenue, Prospects＆Forecasts: 2018-2029
2.3 Global Psychostimulants Sales: 2018-2029
3 Company Landscape
3.1 Top Psychostimulants Players in Global Market
3.2 Top Global Psychostimulants Companies Ranked by Revenue
3.3 Global Psychostimulants Revenue by Companies
3.4 Global Psychostimulants Sales by Companies
3.5 Global Psychostimulants Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Psychostimulants Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Psychostimulants Product Type
3.8 Tier 1, Tier 2 and Tier 3 Psychostimulants Players in Global Market
3.8.1 List of Global Tier 1 Psychostimulants Companies
3.8.2 List of Global Tier 2 and Tier 3 Psychostimulants Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Psychostimulants Market Size Markets, 2022＆2029
4.1.2 Non-prescription Drugs
4.1.3 Prescription
4.2 By Type – Global Psychostimulants Revenue＆Forecasts
4.2.1 By Type – Global Psychostimulants Revenue, 2018-2023
4.2.2 By Type – Global Psychostimulants Revenue, 2024-2029
4.2.3 By Type – Global Psychostimulants Revenue Market Share, 2018-2029
4.3 By Type – Global Psychostimulants Sales＆Forecasts
4.3.1 By Type – Global Psychostimulants Sales, 2018-2023
4.3.2 By Type – Global Psychostimulants Sales, 2024-2029
4.3.3 By Type – Global Psychostimulants Sales Market Share, 2018-2029
4.4 By Type – Global Psychostimulants Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Psychostimulants Market Size, 2022＆2029
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Other
5.2 By Application – Global Psychostimulants Revenue＆Forecasts
5.2.1 By Application – Global Psychostimulants Revenue, 2018-2023
5.2.2 By Application – Global Psychostimulants Revenue, 2024-2029
5.2.3 By Application – Global Psychostimulants Revenue Market Share, 2018-2029
5.3 By Application – Global Psychostimulants Sales＆Forecasts
5.3.1 By Application – Global Psychostimulants Sales, 2018-2023
5.3.2 By Application – Global Psychostimulants Sales, 2024-2029
5.3.3 By Application – Global Psychostimulants Sales Market Share, 2018-2029
5.4 By Application – Global Psychostimulants Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Psychostimulants Market Size, 2022＆2029
6.2 By Region – Global Psychostimulants Revenue＆Forecasts
6.2.1 By Region – Global Psychostimulants Revenue, 2018-2023
6.2.2 By Region – Global Psychostimulants Revenue, 2024-2029
6.2.3 By Region – Global Psychostimulants Revenue Market Share, 2018-2029
6.3 By Region – Global Psychostimulants Sales＆Forecasts
6.3.1 By Region – Global Psychostimulants Sales, 2018-2023
6.3.2 By Region – Global Psychostimulants Sales, 2024-2029
6.3.3 By Region – Global Psychostimulants Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Psychostimulants Revenue, 2018-2029
6.4.2 By Country – North America Psychostimulants Sales, 2018-2029
6.4.3 US Psychostimulants Market Size, 2018-2029
6.4.4 Canada Psychostimulants Market Size, 2018-2029
6.4.5 Mexico Psychostimulants Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Psychostimulants Revenue, 2018-2029
6.5.2 By Country – Europe Psychostimulants Sales, 2018-2029
6.5.3 Germany Psychostimulants Market Size, 2018-2029
6.5.4 France Psychostimulants Market Size, 2018-2029
6.5.5 U.K. Psychostimulants Market Size, 2018-2029
6.5.6 Italy Psychostimulants Market Size, 2018-2029
6.5.7 Russia Psychostimulants Market Size, 2018-2029
6.5.8 Nordic Countries Psychostimulants Market Size, 2018-2029
6.5.9 Benelux Psychostimulants Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Psychostimulants Revenue, 2018-2029
6.6.2 By Region – Asia Psychostimulants Sales, 2018-2029
6.6.3 China Psychostimulants Market Size, 2018-2029
6.6.4 Japan Psychostimulants Market Size, 2018-2029
6.6.5 South Korea Psychostimulants Market Size, 2018-2029
6.6.6 Southeast Asia Psychostimulants Market Size, 2018-2029
6.6.7 India Psychostimulants Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Psychostimulants Revenue, 2018-2029
6.7.2 By Country – South America Psychostimulants Sales, 2018-2029
6.7.3 Brazil Psychostimulants Market Size, 2018-2029
6.7.4 Argentina Psychostimulants Market Size, 2018-2029
6.8 Middle East＆Africa
6.8.1 By Country – Middle East＆Africa Psychostimulants Revenue, 2018-2029
6.8.2 By Country – Middle East＆Africa Psychostimulants Sales, 2018-2029
6.8.3 Turkey Psychostimulants Market Size, 2018-2029
6.8.4 Israel Psychostimulants Market Size, 2018-2029
6.8.5 Saudi Arabia Psychostimulants Market Size, 2018-2029
6.8.6 UAE Psychostimulants Market Size, 2018-2029
7 Manufacturers＆Brands Profiles
7.1 Alkermes
7.1.1 Alkermes Company Summary
7.1.2 Alkermes Business Overview
7.1.3 Alkermes Psychostimulants Major Product Offerings
7.1.4 Alkermes Psychostimulants Sales and Revenue in Global (2018-2023)
7.1.5 Alkermes Key News＆Latest Developments
7.2 Allergan
7.2.1 Allergan Company Summary
7.2.2 Allergan Business Overview
7.2.3 Allergan Psychostimulants Major Product Offerings
7.2.4 Allergan Psychostimulants Sales and Revenue in Global (2018-2023)
7.2.5 Allergan Key News＆Latest Developments
7.3 Bristol-Myers Squibb
7.3.1 Bristol-Myers Squibb Company Summary
7.3.2 Bristol-Myers Squibb Business Overview
7.3.3 Bristol-Myers Squibb Psychostimulants Major Product Offerings
7.3.4 Bristol-Myers Squibb Psychostimulants Sales and Revenue in Global (2018-2023)
7.3.5 Bristol-Myers Squibb Key News＆Latest Developments
7.4 Eli Lilly and Company
7.4.1 Eli Lilly and Company Company Summary
7.4.2 Eli Lilly and Company Business Overview
7.4.3 Eli Lilly and Company Psychostimulants Major Product Offerings
7.4.4 Eli Lilly and Company Psychostimulants Sales and Revenue in Global (2018-2023)
7.4.5 Eli Lilly and Company Key News＆Latest Developments
7.5 GlaxoSmithKline
7.5.1 GlaxoSmithKline Company Summary
7.5.2 GlaxoSmithKline Business Overview
7.5.3 GlaxoSmithKline Psychostimulants Major Product Offerings
7.5.4 GlaxoSmithKline Psychostimulants Sales and Revenue in Global (2018-2023)
7.5.5 GlaxoSmithKline Key News＆Latest Developments
7.6 Lundbeck
7.6.1 Lundbeck Company Summary
7.6.2 Lundbeck Business Overview
7.6.3 Lundbeck Psychostimulants Major Product Offerings
7.6.4 Lundbeck Psychostimulants Sales and Revenue in Global (2018-2023)
7.6.5 Lundbeck Key News＆Latest Developments
7.7 Merck
7.7.1 Merck Company Summary
7.7.2 Merck Business Overview
7.7.3 Merck Psychostimulants Major Product Offerings
7.7.4 Merck Psychostimulants Sales and Revenue in Global (2018-2023)
7.7.5 Merck Key News＆Latest Developments
7.8 Pfizer
7.8.1 Pfizer Company Summary
7.8.2 Pfizer Business Overview
7.8.3 Pfizer Psychostimulants Major Product Offerings
7.8.4 Pfizer Psychostimulants Sales and Revenue in Global (2018-2023)
7.8.5 Pfizer Key News＆Latest Developments
7.9 Teva Pharmaceutical Industries
7.9.1 Teva Pharmaceutical Industries Company Summary
7.9.2 Teva Pharmaceutical Industries Business Overview
7.9.3 Teva Pharmaceutical Industries Psychostimulants Major Product Offerings
7.9.4 Teva Pharmaceutical Industries Psychostimulants Sales and Revenue in Global (2018-2023)
7.9.5 Teva Pharmaceutical Industries Key News＆Latest Developments
7.10 Takeda Pharmaceutical
7.10.1 Takeda Pharmaceutical Company Summary
7.10.2 Takeda Pharmaceutical Business Overview
7.10.3 Takeda Pharmaceutical Psychostimulants Major Product Offerings
7.10.4 Takeda Pharmaceutical Psychostimulants Sales and Revenue in Global (2018-2023)
7.10.5 Takeda Pharmaceutical Key News＆Latest Developments
7.11 Johnson and Johnson
7.11.1 Johnson and Johnson Company Summary
7.11.2 Johnson and Johnson Business Overview
7.11.3 Johnson and Johnson Psychostimulants Major Product Offerings
7.11.4 Johnson and Johnson Psychostimulants Sales and Revenue in Global (2018-2023)
7.11.5 Johnson and Johnson Key News＆Latest Developments
7.12 Sanofi
7.12.1 Sanofi Company Summary
7.12.2 Sanofi Business Overview
7.12.3 Sanofi Psychostimulants Major Product Offerings
7.12.4 Sanofi Psychostimulants Sales and Revenue in Global (2018-2023)
7.12.5 Sanofi Key News＆Latest Developments
7.13 Astrazeneca
7.13.1 Astrazeneca Company Summary
7.13.2 Astrazeneca Business Overview
7.13.3 Astrazeneca Psychostimulants Major Product Offerings
7.13.4 Astrazeneca Psychostimulants Sales and Revenue in Global (2018-2023)
7.13.5 Astrazeneca Key News＆Latest Developments
7.14 Bayer HealthCare Pharmaceuticals
7.14.1 Bayer HealthCare Pharmaceuticals Company Summary
7.14.2 Bayer HealthCare Pharmaceuticals Business Overview
7.14.3 Bayer HealthCare Pharmaceuticals Psychostimulants Major Product Offerings
7.14.4 Bayer HealthCare Pharmaceuticals Psychostimulants Sales and Revenue in Global (2018-2023)
7.14.5 Bayer HealthCare Pharmaceuticals Key News＆Latest Developments
7.15 Boehringer Ingelheim GmbH
7.15.1 Boehringer Ingelheim GmbH Company Summary
7.15.2 Boehringer Ingelheim GmbH Business Overview
7.15.3 Boehringer Ingelheim GmbH Psychostimulants Major Product Offerings
7.15.4 Boehringer Ingelheim GmbH Psychostimulants Sales and Revenue in Global (2018-2023)
7.15.5 Boehringer Ingelheim GmbH Key News＆Latest Developments
8 Global Psychostimulants Production Capacity, Analysis
8.1 Global Psychostimulants Production Capacity, 2018-2029
8.2 Psychostimulants Production Capacity of Key Manufacturers in Global Market
8.3 Global Psychostimulants Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities＆Trends
9.2 Market Drivers
9.3 Market Restraints
10 Psychostimulants Supply Chain Analysis
10.1 Psychostimulants Industry Value Chain
10.2 Psychostimulants Upstream Market
10.3 Psychostimulants Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Psychostimulants Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Psychostimulants in Global Market
Table 2. Top Psychostimulants Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Psychostimulants Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Psychostimulants Revenue Share by Companies, 2018-2023
Table 5. Global Psychostimulants Sales by Companies, (K Units), 2018-2023
Table 6. Global Psychostimulants Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Psychostimulants Price (2018-2023)＆(US$/Unit)
Table 8. Global Manufacturers Psychostimulants Product Type
Table 9. List of Global Tier 1 Psychostimulants Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Psychostimulants Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Psychostimulants Revenue, (US$, Mn), 2022＆2029
Table 12. By Type - Global Psychostimulants Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Psychostimulants Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Psychostimulants Sales (K Units), 2018-2023
Table 15. By Type - Global Psychostimulants Sales (K Units), 2024-2029
Table 16. By Application – Global Psychostimulants Revenue, (US$, Mn), 2022＆2029
Table 17. By Application - Global Psychostimulants Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Psychostimulants Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Psychostimulants Sales (K Units), 2018-2023
Table 20. By Application - Global Psychostimulants Sales (K Units), 2024-2029
Table 21. By Region – Global Psychostimulants Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Psychostimulants Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Psychostimulants Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Psychostimulants Sales (K Units), 2018-2023
Table 25. By Region - Global Psychostimulants Sales (K Units), 2024-2029
Table 26. By Country - North America Psychostimulants Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Psychostimulants Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Psychostimulants Sales, (K Units), 2018-2023
Table 29. By Country - North America Psychostimulants Sales, (K Units), 2024-2029
Table 30. By Country - Europe Psychostimulants Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Psychostimulants Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Psychostimulants Sales, (K Units), 2018-2023
Table 33. By Country - Europe Psychostimulants Sales, (K Units), 2024-2029
Table 34. By Region - Asia Psychostimulants Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Psychostimulants Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Psychostimulants Sales, (K Units), 2018-2023
Table 37. By Region - Asia Psychostimulants Sales, (K Units), 2024-2029
Table 38. By Country - South America Psychostimulants Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Psychostimulants Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Psychostimulants Sales, (K Units), 2018-2023
Table 41. By Country - South America Psychostimulants Sales, (K Units), 2024-2029
Table 42. By Country - Middle East＆Africa Psychostimulants Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East＆Africa Psychostimulants Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East＆Africa Psychostimulants Sales, (K Units), 2018-2023
Table 45. By Country - Middle East＆Africa Psychostimulants Sales, (K Units), 2024-2029
Table 46. Alkermes Company Summary
Table 47. Alkermes Psychostimulants Product Offerings
Table 48. Alkermes Psychostimulants Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. Alkermes Key News＆Latest Developments
Table 50. Allergan Company Summary
Table 51. Allergan Psychostimulants Product Offerings
Table 52. Allergan Psychostimulants Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. Allergan Key News＆Latest Developments
Table 54. Bristol-Myers Squibb Company Summary
Table 55. Bristol-Myers Squibb Psychostimulants Product Offerings
Table 56. Bristol-Myers Squibb Psychostimulants Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. Bristol-Myers Squibb Key News＆Latest Developments
Table 58. Eli Lilly and Company Company Summary
Table 59. Eli Lilly and Company Psychostimulants Product Offerings
Table 60. Eli Lilly and Company Psychostimulants Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. Eli Lilly and Company Key News＆Latest Developments
Table 62. GlaxoSmithKline Company Summary
Table 63. GlaxoSmithKline Psychostimulants Product Offerings
Table 64. GlaxoSmithKline Psychostimulants Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. GlaxoSmithKline Key News＆Latest Developments
Table 66. Lundbeck Company Summary
Table 67. Lundbeck Psychostimulants Product Offerings
Table 68. Lundbeck Psychostimulants Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 69. Lundbeck Key News＆Latest Developments
Table 70. Merck Company Summary
Table 71. Merck Psychostimulants Product Offerings
Table 72. Merck Psychostimulants Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. Merck Key News＆Latest Developments
Table 74. Pfizer Company Summary
Table 75. Pfizer Psychostimulants Product Offerings
Table 76. Pfizer Psychostimulants Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 77. Pfizer Key News＆Latest Developments
Table 78. Teva Pharmaceutical Industries Company Summary
Table 79. Teva Pharmaceutical Industries Psychostimulants Product Offerings
Table 80. Teva Pharmaceutical Industries Psychostimulants Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 81. Teva Pharmaceutical Industries Key News＆Latest Developments
Table 82. Takeda Pharmaceutical Company Summary
Table 83. Takeda Pharmaceutical Psychostimulants Product Offerings
Table 84. Takeda Pharmaceutical Psychostimulants Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 85. Takeda Pharmaceutical Key News＆Latest Developments
Table 86. Johnson and Johnson Company Summary
Table 87. Johnson and Johnson Psychostimulants Product Offerings
Table 88. Johnson and Johnson Psychostimulants Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 89. Johnson and Johnson Key News＆Latest Developments
Table 90. Sanofi Company Summary
Table 91. Sanofi Psychostimulants Product Offerings
Table 92. Sanofi Psychostimulants Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 93. Sanofi Key News＆Latest Developments
Table 94. Astrazeneca Company Summary
Table 95. Astrazeneca Psychostimulants Product Offerings
Table 96. Astrazeneca Psychostimulants Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 97. Astrazeneca Key News＆Latest Developments
Table 98. Bayer HealthCare Pharmaceuticals Company Summary
Table 99. Bayer HealthCare Pharmaceuticals Psychostimulants Product Offerings
Table 100. Bayer HealthCare Pharmaceuticals Psychostimulants Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 101. Bayer HealthCare Pharmaceuticals Key News＆Latest Developments
Table 102. Boehringer Ingelheim GmbH Company Summary
Table 103. Boehringer Ingelheim GmbH Psychostimulants Product Offerings
Table 104. Boehringer Ingelheim GmbH Psychostimulants Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 105. Boehringer Ingelheim GmbH Key News＆Latest Developments
Table 106. Psychostimulants Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 107. Global Psychostimulants Capacity Market Share of Key Manufacturers, 2021-2023
Table 108. Global Psychostimulants Production by Region, 2018-2023 (K Units)
Table 109. Global Psychostimulants Production by Region, 2024-2029 (K Units)
Table 110. Psychostimulants Market Opportunities＆Trends in Global Market
Table 111. Psychostimulants Market Drivers in Global Market
Table 112. Psychostimulants Market Restraints in Global Market
Table 113. Psychostimulants Raw Materials
Table 114. Psychostimulants Raw Materials Suppliers in Global Market
Table 115. Typical Psychostimulants Downstream
Table 116. Psychostimulants Downstream Clients in Global Market
Table 117. Psychostimulants Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Psychostimulants Segment by Type in 2022
Figure 2. Psychostimulants Segment by Application in 2022
Figure 3. Global Psychostimulants Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Psychostimulants Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Psychostimulants Revenue, 2018-2029 (US$, Mn)
Figure 7. Psychostimulants Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Psychostimulants Revenue in 2022
Figure 9. By Type - Global Psychostimulants Revenue, (US$, Mn), 2022＆2029
Figure 10. By Type - Global Psychostimulants Revenue Market Share, 2018-2029
Figure 11. By Type - Global Psychostimulants Sales Market Share, 2018-2029
Figure 12. By Type - Global Psychostimulants Price (US$/Unit), 2018-2029
Figure 13. By Application - Global Psychostimulants Revenue, (US$, Mn), 2022＆2029
Figure 14. By Application - Global Psychostimulants Revenue Market Share, 2018-2029
Figure 15. By Application - Global Psychostimulants Sales Market Share, 2018-2029
Figure 16. By Application - Global Psychostimulants Price (US$/Unit), 2018-2029
Figure 17. By Region - Global Psychostimulants Revenue, (US$, Mn), 2022＆2029
Figure 18. By Region - Global Psychostimulants Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Psychostimulants Revenue Market Share, 2018-2029
Figure 20. By Region - Global Psychostimulants Sales Market Share, 2018-2029
Figure 21. By Country - North America Psychostimulants Revenue Market Share, 2018-2029
Figure 22. By Country - North America Psychostimulants Sales Market Share, 2018-2029
Figure 23. US Psychostimulants Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Psychostimulants Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Psychostimulants Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Psychostimulants Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Psychostimulants Sales Market Share, 2018-2029
Figure 28. Germany Psychostimulants Revenue, (US$, Mn), 2018-2029
Figure 29. France Psychostimulants Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Psychostimulants Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Psychostimulants Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Psychostimulants Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Psychostimulants Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Psychostimulants Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Psychostimulants Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Psychostimulants Sales Market Share, 2018-2029
Figure 37. China Psychostimulants Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Psychostimulants Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Psychostimulants Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Psychostimulants Revenue, (US$, Mn), 2018-2029
Figure 41. India Psychostimulants Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Psychostimulants Revenue Market Share, 2018-2029
Figure 43. By Country - South America Psychostimulants Sales Market Share, 2018-2029
Figure 44. Brazil Psychostimulants Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Psychostimulants Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East＆Africa Psychostimulants Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East＆Africa Psychostimulants Sales Market Share, 2018-2029
Figure 48. Turkey Psychostimulants Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Psychostimulants Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Psychostimulants Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Psychostimulants Revenue, (US$, Mn), 2018-2029
Figure 52. Global Psychostimulants Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Psychostimulants by Region, 2022 VS 2029
Figure 54. Psychostimulants Industry Value Chain
Figure 55. Marketing Channels


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 関節リウマチ用医薬品のグローバル市場展望 2023年-2029年：医療用医薬品、一般用医薬品
  • 凍結乾燥口腔内崩壊錠のグローバル市場展望 2023年-2029年：医療用医薬品、一般用医薬品
  • 矯正歯科用テレデンティストリーのグローバル市場展望 2023年-2029年：非同期、同期、その他
  • 薄膜ドラッグデリバリーのグローバル市場展望 2023年-2029年：口腔用薄膜、経皮用フィルム、その他
  • 肝臓用サプリメントのグローバル市場展望 2023年-2029年：錠剤、粉末、液体
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(MMG23DC14537 )"精神刺激薬のグローバル市場展望 2023年-2029年：一般用医薬品、処方箋医薬品" (英文：Psychostimulants Market, Global Outlook and Forecast 2023-2029)はMarket Monitor Global社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。